Amedeo's Top 20

Amedeo Smart

Independent Medical Education


22 July 2019

Multidisciplinary Journal Club

  1. Utjes D, Malmstedt J, Teras J, Drzewiecki K, et al.
    2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: long-term follow-up of a multicentre, randomised trial.
    Lancet 2019.

  1. Laplaud DA, Casey R, Barbin L, Debouverie M, et al.
    Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis.
    Neurology 2019.

  2. Martin NK, Jansen K, An der Heiden M, Boesecke C, et al.
    Can HCV be eliminated among HIV-positive men who have sex with men in Berlin? A modeling analysis.
    J Infect Dis 2019.

  3. Feng Q, Zhou A, Zou H, Ingle S, et al.
    Quadruple versus triple combination antiretroviral therapies for treatment naive people with HIV: systematic review and meta-analysis of randomised controlled trials.
    BMJ 2019;366:l4179.

  4. Insel PS, Weiner M, Mackin RS, Mormino E, et al.
    Determining clinically meaningful decline in preclinical Alzheimer disease.
    Neurology 2019.

  1. Betson M, Clifford S, Stanton M, Kabatereine NB, et al.
    Emergence of non-falciparum Plasmodium infection despite regular artemisinin combination therapy in a 18-month longitudinal study of Ugandan children and their mothers.
    J Infect Dis 2018.

  2. Rulli E, Legramandi L, Salvati L, Mandala M, et al.
    The impact of targeted therapies and immunotherapy in melanoma brain metastases: A systematic review and meta-analysis.
    Cancer 2019.

  3. Del Din S, Elshehabi M, Galna B, Hobert M, et al.
    Gait analysis with wearables predicts conversion to Parkinson's disease.
    Ann Neurol 2019.

  4. Raman AS, Gehrig JL, Venkatesh S, Chang HW, et al.
    A sparse covarying unit that describes healthy and impaired human gut microbiota development.
    Science 2019;365.

  5. Litton E, Latham P, Inman J, Luo J, et al.
    Safety and efficacy of erythropoiesis-stimulating agents in critically ill patients admitted to the intensive care unit: a systematic review and meta-analysis.
    Intensive Care Med 2019.

  1. Khan SU, Khan MU, Riaz H, Valavoor S, et al.
    Effects of Nutritional Supplements and Dietary Interventions on Cardiovascular Outcomes: An Umbrella Review and Evidence Map.
    Ann Intern Med 2019.

  2. Galanis E, Anderson SK, Twohy EL, Carrero XW, et al.
    A phase 1 and randomized, placebo-controlled phase 2 trial of bevacizumab plus dasatinib in patients with recurrent glioblastoma: Alliance/North Central Cancer Treatment Group N0872.
    Cancer 2019.

  3. Puopolo KM, Lynfield R, Cummings JJ.
    Management of Infants at Risk for Group B Streptococcal Disease.
    Pediatrics 2019.

  4. Knight M, Chiocchia V, Partlett C, Rivero-Arias O, et al.
    Prophylactic antibiotics in the prevention of infection after operative vaginal delivery (ANODE): a multicentre randomised controlled trial.
    Lancet 2019;393:2395-2403.

  5. Sachdeva R, Wu M, Smiljanic S, Kaskun O, et al.
    ID1 Is Critical for Tumorigenesis and Regulates Chemoresistance in Glioblastoma.
    Cancer Res 2019.

  1. Macatangay BJC, Jackson EK, Abebe KZ, Comer D, et al.
    A Randomized, Placebo-Controlled, Pilot Clinical Trial of Dipyridamole to Decrease Hiv-Associated Chronic Inflammation.
    J Infect Dis 2019.

  2. Serpa JA, Huynh GN, Nickell JB, Miao H, et al.
    HIV Pre-Exposure Prophylaxis and Increased Incidence of Sexually Transmitted Infections in the United States.
    Clin Infect Dis 2019.

  3. Freeman CL, Kridel R, Moccia AA, Savage KJ, et al.
    Early progression after BR is associated with high risk of transformation in advanced stage follicular lymphoma.
    Blood 2019.

  4. Staber PB, Herling M, Bellido M, Jacobsen ED, et al.
    Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia (T-PLL).
    Blood 2019.

  5. Azam S, Eriksson M, Sjolander A, Hellgren R, et al.
    Mammographic Density Change and Risk of Breast Cancer.
    J Natl Cancer Inst 2019.


more..


Privacy Policy